A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test safety and efficacy of this combination treatment
(IMGN901, carboplatin and etoposide) in patients with solid tumors and extensive stage small
cell lung cancer.